Search

everythinglearnresearchcommunity

for

Search:↓

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Blood metabolites significantly influence alopecia areata risk.

Catechins-rich tea extract may help reduce hair loss and promote hair growth.

Baby teeth stem cells can potentially grow organs and treat diseases.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

Trichohyalin may trigger the immune response causing alopecia areata.

ALRN-6924 may prevent hair loss caused by chemotherapy.

BTNL2 helps protect hair follicles from immune attacks.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Potential therapeutic targets for scarring hair loss are identified.

Alopecia areata is caused by the immune system attacking hair follicles.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Enhancing Tregs can protect against alopecia areata.

The Fas/FasL pathway may play a role in alopecia areata.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

ILC1-like cells can cause alopecia areata by themselves.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.